All peptides referenced are intended strictly for laboratory research use and are not approved for human consumption, diagnosis, or treatment of any medical condition
PlexusDx recommends monitoring your blood glucose closely if you choose to drink while on tirzepatide, especially during the first few weeks of treatment or after a dose increase
In subjects with T2DM, weekly administration of tirzepatide at doses of 5 mg, 10 mg, or 15 mg was associated with greater weight loss compared to placebo ( 6.3 kg, 8.4 kg, and 9.4 kg, respectively), and 1.7 kg, 4.8 kg, and 7.2 kg greater weight loss compared to selective GLP-1 receptor agonists, demonstrating a dose-dependent effect sustained for up to 2 years [48]
they are looking for injunctions